News

Medical device companies often face challenges during biological evaluation and regulatory review, including incomplete test coverage, insufficient data depth, and gaps in immunotoxicity or blood compatibility assessments.

On June 30, 2025, MDL officially obtained accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), marking a significant milestone in its quality management system and laboratory capabilities.